The possibility of selectively targeting subsets may give rise to monocyte-based therapeutics for chronic inflammatory conditions such as atherosclerosis, as well as for improvement of healing after acute myocardial infarction.This study points to an active role for circulating Ly-6Clo monocytes during healing and argues against in situ conversion as a dominant mechanism by which Ly-6Clo cells app